Endoscopic Management of Cholangiocarcinoma

Cholangiocarcinoma (CCA) is an uncommon malignant tumor arising from the biliary epithelium. The incidence increases with age and usually affects individuals in their 6th or 7th decade of life. Those patients with underlying risk factors such as primary sclerosing cholangitis (PSC) and choledochal cysts generally present 2 decades earlier. Most patients clinically present with painless jaundice; however, other common symptoms include pruritis, weight loss, and abdominal pain. Although surgical resection offers the only hope for cure, most patients are found to have unresectable disease on initial presentation and have an extremely grim prognosis. This has led to an emphasis on the role of palliative care, with relief of biliary obstruction, in the management of these patients. Surgical bypass was once the primary means of palliation of jaundice in patients with unresectable cholangiocarcinoma but in the last 2 decades has been superseded by less invasive and less morbid nonsurgical procedures such as endoscopic and percutaneous biliary stent placement. Newer modalities of palliation such as endoscopic delivery of photodynamic therapy and high-intensity ultrasound therapy are emerging nonsurgical modalities that may result in improved survival and may play a future role as an adjunctive therapy to surgical resection.

KEYWORDS

Cholangiocarcinoma - endoscopic retrograde cholangiopancreatography - biliary tract neoplasms - stents - magnetic resonance imaging

REFERENCES

• 1 Nakeeb A, Pitt H A, Sohn T A et al.. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors.  Ann Surg. 1996;  224 463-473
• 2 Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer.  World J Surg. 1988;  12 39-47
• 3 Chapman R W. Risk factors for biliary tract carcinogenesis.  Ann Oncol. 1999;  10(Suppl 4) 308-311
• 4 de Groen P C, Gores G J, LaRusso N F et al.. Biliary tract cancers.  N Engl J Med. 1999;  341 1368-1378
• 5 Chamberlain R S, Blumgart L H. Hilar cholangiocarcinoma: a review and commentary.  Ann Surg Oncol. 2000;  7 55-66
• 6 Henke A C, Jensen C S, Cohen M B. Cytologic diagnosis of adenocarcinoma in biliary and pancreatic duct brushings.  Adv Anat Pathol. 2002;  9 301-308
• 7 Sugiyama M, Atomi Y, Wada N et al.. Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparison with bile and brush cytology.  Am J Gastroenterol. 1996;  91 465-467
• 8 Ponchon T, Gagnon P, Berger F et al.. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study.  Gastrointest Endosc. 1995;  42 565-572
• 9 Kubota Y, Takaoka M, Tani K et al.. Endoscopic transpapillary biopsy for diagnosis of patients with pancreaticobiliary ductal strictures.  Am J Gastroenterol. 1993;  88 1700-1704
• 10 Rabinovitz M, Zajko A B, Hassanein T et al.. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures.  Hepatology. 1990;  12 747-752
• 11 Rumalla A, Baron T H, Leontovich O et al.. Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis.  Mayo Clin Proc. 2001;  76 29-33
• 12 Baron T H, Harewood G C, Rumalla A. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures.  Clin Gastroenterol Hepatol. 2004;  2 214-219
• 13 Vauthey J N, Blumgart L H. Recent advances in the management of cholangiocarcinomas.  Semin Liver Dis. 1994;  14 109-114
• 14 Ahrendt S A, Nakeeb A, Pitt H A. Cholangiocarcinoma.  Clin Liver Dis. 2001;  5 191-218
• 15 Stadheim L M, Pochron N L, Huiras S A et al.. A prospective comparison of fluorescence in situ hybridization (FISH) and routine cytology (RC) for the identification of malignancy in biliary tract strictures.  Gastroenterology. 2001;  120(suppl 1) A607
• 16 Fritscher-Ravens A, Broering D C, Sriram P V. EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series.  Gastrointest Endosc. 2000;  52 534-540
• 17 Polydorou A A, Cairns S R, Dowsett J F et al.. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion.  Gut. 1991;  32 685-689
• 18 Smith A C, Dowsett J F, Russell R C, Hatfield A R, Cotton P B. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction.  Lancet. 1994;  344 1655-1660
• 19 Andersen J R, Sorensen S M, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice.  Gut. 1989;  30 1132-1135
• 20 Shepherd H A, Royle G, Ross A P et al.. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial.  Br J Surg. 1988;  75 1166-1168
• 21 Lai E C, Chu K M, Lo C Y et al.. Choice of palliation for malignant hilar biliary obstruction.  Am J Surg. 1992;  163 208-212
• 22 Stain S C, Baer H U, Dennison A R, Blumgart L H. Current management of hilar cholangiocarcinoma.  Surg Gynecol Obstet. 1992;  175 579-588
• 23 Raijman I. Biliary and pancreatic stents.  Gastrointest Endosc Clin N Am. 2003;  13 561-592
• 24 Dowsett J F, Vaira D, Hatfield A R et al.. Endoscopic biliary therapy using the combined percutaneous and endoscopic technique.  Gastroenterology. 1989;  96 1180-1186
• 25 Deviere J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage.  Gastrointest Endosc. 1988;  34 95-101
• 26 Chang W H, Kortan P, Haber G B. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage.  Gastrointest Endosc. 1998;  47 354-362
• 27 De Palma G D, Galloro G, Siciliano S et al.. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study.  Gastrointest Endosc. 2001;  53 547-553
• 28 De Palma G D, Pezzullo A, Rega M et al.. Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study.  Gastrointest Endosc. 2003;  58 50-53
• 29 Sherman S. Endoscopic drainage of malignant hilar obstruction: is one biliary stent enough or should we work to place two?.  Gastrointest Endosc. 2001;  53 681-684
• 30 Hintze R E, Abou-Rebyeh H, Adler A et al.. Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors.  Gastrointest Endosc. 2001;  53 40-46
• 31 Kaassis M, Boyer J, Dumas R et al.. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study.  Gastrointest Endosc. 2003;  57 178-182
• 32 Peters R A, Williams S G, Lombard M et al.. The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses.  Endoscopy. 1997;  29 10-16
• 33 Freeman M L, Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.  Gastrointest Endosc. 2003;  58 41-49
• 34 Bruha R, Petrtyl J, Kubecova M et al.. Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies-the question of long-term palliation.  Hepatogastroenterology. 2001;  48 631-637
• 35 Montemaggi P, Costamagna G, Dobelbower R R et al.. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.  Int J Radiat Oncol Biol Phys. 1995;  32 437-443
• 36 Gerhards M F, van Gulik T M, Gonzalez Gonzalez D, Rauws E A, Gouma D J. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.  World J Surg. 2003;  27 173-179
• 37 Ortner M E, Caca K, Berr F et al.. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.  Gastroenterology. 2003;  125 1355-1363
• 38 Prat F, Lafon C, Margonari J et al.. A high-intensity US probe designed for intraductal tumor destruction: experimental results.  Gastrointest Endosc. 1999;  50 388-392
• 39 Prat F, Lafon C, Theilliere J Y et al.. Destruction of a bile duct carcinoma by intraductal high intensity ultrasound during ERCP.  Gastrointest Endosc. 2001;  53 797-800
• 40 Prat F, Lafon C, De Lima D M et al.. Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: results of a pilot study.  Gastrointest Endosc. 2002;  56 909-915